肝内胆管癌:影像学在多学科治疗模式中的关键作用
本文综述肝内胆管癌(iCCA)的流行病学、危险因素及影像学在多学科治疗中的核心作用,指出iCCA发病率逐年上升,早期诊断和基于分期的治疗可改善生存,影像学在准确诊断、分期及可切除性评估中发挥关键作用。
要点
- iCCA占胆管癌的10-20%,起源于二级胆管及其近端,早期识别困难常导致治疗延迟。
- 影像学是iCCA多学科治疗的核心组成,用于准确诊断、分期及可切除性评估。
- iCCA发病率上升,美国达每年每10万人1.26例,全球达每年每10万人3.3例。
核心结论
- 影像学在iCCA诊断中居核心地位,是多学科综合治疗规划的关键环节,有助于为每位患者制定最佳治疗方案。
研究设计与样本
- 综述性文章,总结肝内胆管癌的流行病学、危险因素及影像学在多学科治疗中的作用,未报告系统检索范围与纳入文献数量。
临床应用与阅片要点
- 影像学用于iCCA的准确诊断、分期及可切除性评估,以支持多学科治疗决策;多学科治疗模式通过整合影像诊断、组织学诊断、分期、可切除性评估及系统/靶向或肝脏导向治疗,可能改善患者结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cholangiocarcinoma (CCA) is a unifying title granted to epithelial adenocarcinomas specific to the bile ducts making up 10-25% of all hepatobiliary malignancies. CCA is more appropriately classified based on anatomic site of origin within the biliary tract into intrahepatic cholangiocarcinoma (iCCA), peri-hilar (pCCA) cholangiocarcinoma, and distal cholangiocarcinoma (dCCA). Intrahepatic cholangiocarcinoma makes up 10-20% of CCA and originates within and/or proximal to the second order bile ducts. The incidence of iCCA has been rising overtime with up to 1.26 per 100,000 persons, per year in the United States and up to 3.3 per 100, 000 persons, per year affected globally. Risk factors include chronic hepatic inflammation secondary to viral hepatitis, alcohol/NASH cirrhosis, biliary cystic lesions, and endemic causes, among other less common genetic drivers. Given its rarity, the recognition and diagnosis of cholangiocarcinoma, iCCA specifically, remains challenging resulting in delays in treatment initiation or any treatment at all. Median overall survival (mOS) for iCCA remains low. Early diagnosis, and stage-based treatment approaches have evolved and are associated with improved survival. To this goal, a multi-disciplinary treatment approach has been demonstrated to improve patient outcomes by providing expert evaluation as it pertains to an accurate imaging and histologic diagnosis, staging, radiologic and surgical review for resectability, operative expertise, post operative care, as well as comprehensive knowledge and implementation of systemic/targeted or liver directed therapies. Here, we discuss the central role of imaging in the diagnosis of intrahepatic cholangiocarcinoma to implement a comprehensive treatment plan that frequently involves multiple disciplines to achieve the best outcome for each patient.
引用
- Childers BG, Denbo JW, Kim RD, et al. Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approach. Abdom Radiol (NY). 2025. PMID: 40095023. doi:10.1007/s00261-025-04856-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。